Tick-Borne Encephalitis vaccine

BIOLOGICAL4 trials

Sponsors

Pfizer, Novartis

Conditions

Encephalitis, Tick-BorneTick-borne Encephalitis

Phase 2

Dose-finding Study to Investigate the Safety and Immunogenicity of Two Vaccinations With FSME IMMUN NEW in Healthy Volunteers Aged 1 to 6 Years.

CompletedNCT00161772

PfizerTick-borne Encephalitis

Start: 2002-03-31End: 2002-08-31Updated: 2015-05-21

Dose-finding Study to Investigate the Safety and Immunogenicity of Two Vaccinations With FSME IMMUN NEW in Healthy Volunteers Aged 6 to 16 Years.

CompletedNCT00161798

PfizerTick-borne Encephalitis

Start: 2001-09-30End: 2002-03-31Updated: 2015-05-21

Phase 4

Study of the Safety, Tolerability and Immune Response of TBE Vaccines Administered to Healthy Children

CompletedNCT00311441

NovartisEncephalitis, Tick-Borne

Start: 2005-03-31Target: 300Updated: 2008-03-17

Evaluation of Long-Term Immunogenicity in Subjects Boosted With a TBE Vaccine for Adults

CompletedNCT00311493

NovartisEncephalitis, Tick-Borne

Start: 2006-02-28Target: 179Updated: 2007-03-13